XML 67 R35.htm IDEA: XBRL DOCUMENT v3.20.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Share-Based Compensation Expense

The amount of share-based compensation expense recognized by the Company by location in its statements of operations for the three months ended March 31, 2020 and 2019 is as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2020

 

 

2019

 

Cost of revenues

 

$

16

 

 

$

10

 

Sales and marketing

 

 

430

 

 

 

204

 

General and administrative

 

 

607

 

 

 

218

 

Research and development

 

 

143

 

 

 

69

 

Total

 

$

1,196

 

 

$

501

 

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity for the three months ended March 31, 2020:

 

 

 

Number of

Shares under

Option

(in thousands)

 

 

Weighted-

average

Exercise Price

per Option

 

 

Weighted-

average

Remaining

Contractual

Life (in years)

 

 

Aggregate

Intrinsic

Value

(in thousands)

 

Outstanding at December 31, 2019

 

 

2,415

 

 

$

7.11

 

 

 

 

 

 

 

 

 

Granted

 

 

28

 

 

$

2.94

 

 

 

 

 

 

 

 

 

Exercised

 

 

(49

)

 

$

1.56

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(70

)

 

$

12.01

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2020

 

 

2,324

 

 

$

7.03

 

 

 

7.3

 

 

$

553

 

Exercisable at March 31, 2020

 

 

1,277

 

 

$

4.02

 

 

 

6.2

 

 

$

553

 

Vested and expected to vest at March 31, 2020

 

 

2,324

 

 

$

7.03

 

 

 

7.3

 

 

$

553

 

Summary of Weighted-average Inputs and Assumptions used to Estimate Grant-date Fair Value of Stock Options

For the three months ended March 31, 2020, the grant-date fair value of stock options was estimated at the time of grant using the following weighted-average inputs and assumptions in the Black-Scholes option pricing model:

 

Estimated fair value of common stock

 

$

2.94

 

Exercise price

 

$

2.94

 

Expected term (in years)

 

 

6.1

 

Risk-free interest rate

 

 

0.9

%

Expected volatility

 

 

55.3

%

Dividend yield

 

 

0

%

Summary of Restricted Stock Award and Restricted Stock Unit Activity

The following table summarizes the Company’s restricted stock award and restricted stock unit activity for the three months ended March 31, 2020:

 

 

 

Non-vested

Restricted

Stock Units

(in thousands)

 

 

Weighted-

average

Grant-date

Fair Value

 

Non-vested at December 31, 2019

 

 

245

 

 

$

15.23

 

Granted

 

 

1,331

 

 

$

3.58

 

Vested

 

 

(32

)

 

$

14.12

 

Forfeited

 

 

(22

)

 

$

4.79

 

Non-vested at March 31, 2020

 

 

1,522

 

 

$

5.22